One Hygeia Healthcare Holdings Insider Raised Their Stake In The Previous Year
One Hygeia Healthcare Holdings Insider Raised Their Stake In The Previous Year
From what we can see, insiders were net buyers in Hygeia Healthcare Holdings Co., Limited's (HKG:6078 ) during the past 12 months. That is, insiders acquired the stock in greater numbers than they sold it.
根据我们所看到的,内部人士在过去12个月内是净买入的,购买了Hygeia Healthcare Holdings Co., Limited(HKG:6078)的股票,也就是说,内部人士购买的股票数量大于他们卖出的数量。
Although we don't think shareholders should simply follow insider transactions, we would consider it foolish to ignore insider transactions altogether.
虽然我们不认为股东应该简单地跟随内部交易,但完全忽略内部交易将是愚蠢的。
Hygeia Healthcare Holdings Insider Transactions Over The Last Year
Hygeia Healthcare Holdings内部人士在过去一年的交易
Over the last year, we can see that the biggest insider purchase was by Chairman & Co-CEO Yiwen Zhu for HK$20m worth of shares, at about HK$36.59 per share. That means that even when the share price was higher than HK$15.54 (the recent price), an insider wanted to purchase shares. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We always take careful note of the price insiders pay when purchasing shares. It is encouraging to see an insider paid above the current price for shares, as it suggests they saw value, even at higher levels. The only individual insider to buy over the last year was Yiwen Zhu.
在过去一年中,我们看到最大的内部人士购买是由董事长兼联合首席执行官朱怡文以价值2000万港元的价格购买的股票,约为每股36.59港元。这意味着即使在股价高于15.54港元(最近价格)时,某位内部人士仍然希望购买股票。虽然他们的看法在购买后可能发生了变化,但至少这表明他们对公司的未来有信心。我们始终认真关注内部人士在购买股票时支付的价格。看到某位内部人士以高于当前价格购买股票令人鼓舞,因为这表明他们在更高的价格水平上也看到了价值。过去一年中唯一买入的内部人士是朱怡文。
Yiwen Zhu purchased 1.91m shares over the year. The average price per share was HK$31.33. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!
朱怡文在过去一年中购买了191万股。每股平均价格为31.33港元。您可以在下面的图表中看到过去一年内部人士(公司和个人)的交易情况。通过点击下面的图表,您可以查看每笔内部交易的详细信息!
Hygeia Healthcare Holdings is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.
海吉亚医疗控股并不是唯一一个内部人士在买入的股票。对于那些喜欢寻找有吸引力估值的小盘公司的投资者来说,这份有近期内部人士购买的成长型公司的免费名单可能正是所需。
Does Hygeia Healthcare Holdings Boast High Insider Ownership?
海吉亚医疗控股是否拥有高比例的内部人士股份?
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. Hygeia Healthcare Holdings insiders own 46% of the company, currently worth about HK$4.4b based on the recent share price. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.
测试公司领导层与其他股东之间的对齐度的另一种方式是查看他们拥有多少股份。内部人士的高持股比例通常使公司领导层更加关注股东利益。海吉亚医疗控股的内部人士持有公司46%的股份,按最近的股价计算,当前价值约为HK$44亿。我喜欢看到这样的内部持股比例,因为这增加了管理层关注股东最大利益的可能性。
So What Do The Hygeia Healthcare Holdings Insider Transactions Indicate?
那么,海吉亚医疗控股的内部交易表明了什么?
The fact that there have been no Hygeia Healthcare Holdings insider transactions recently certainly doesn't bother us. But insiders have shown more of an appetite for the stock, over the last year. It would be great to see more insider buying, but overall it seems like Hygeia Healthcare Holdings insiders are reasonably well aligned (owning significant chunk of the company's shares) and optimistic for the future. Therefore, you should definitely take a look at this FREE report showing analyst forecasts for Hygeia Healthcare Holdings.
最近没有海吉亚医疗控股的内部交易的事实当然不会让我们感到困扰。但在过去的一年中,内部人士对该股票的兴趣更高。看到更多的内部买入会很好,但总体来看,海吉亚医疗控股的内部人士似乎在合理对齐(持有公司大量股份)并对未来持乐观态度。因此,您绝对应该查看这份免费报告,了解分析师对海吉亚医疗控股的预测。
Of course Hygeia Healthcare Holdings may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
当然,Hygeia Healthcare Holdings 可能不是最值得买入的股票。所以你可能想看看这一免费优质公司的集合。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
对于本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前仅考虑公开市场交易和直接利益的私人处置,但不包括衍生交易或间接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。